Compare · 2 funds side by side · dividends reinvested

SBIO and XLV

SBIOALPS×XLVSPDR×

Versus in desk

02 / 04

−0.1%

IWD+0.2%

Search ETFs and stocks

Portfolio

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$15,419XLV · best of the two

Story of the two · IncomeMost incomeXLV · 1.35% · $135 a year on $10k

Story of the two · RiskSmallest drop

SBIO and XLV, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

State Street Health Care Select Sector SPDR ETFSectors · Health care0.08%1.35%+23.5%+25.6%+15.7%+9.0%−10.5%16.8%$50.6B1.1

ALPS Medical Breakthroughs ETFSectors · Health care0.50%0.00%+8.6%+20.4%+32.1%+3.6%−29.2%33.5%$186M1.9

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 13, 2026 · returns include dividends · since: SBIO 2014 · XLV 1998

Head to Head

Swap sides Versus in desk

Head to Head

5Y

ALPS Medical Breakthroughs ETF · $186M$11,920

SBIO

XLV

State Street Health Care Select Sector SPDR ETF · $50.6B$15,419

$10,000 five years ago, dividends reinvested · they hold 0.0% in common

SBIOMeasureXLV

+8.6%

More Ways to See the Pairs

SBIO vs XLV: Top 5 Holdings

Today

SBIO

18.9%in top 5

XLV

in top 544.9%

SBIOStockXLV

not top 5LLY16.8%

not top 5JNJ9.9%

not top 5ABBV7.6%

not top 5MRK5.3%

not top 5UNH5.3%

Cost, Income and Risk

Fees: SBIO, XLV

Today

0.08%lowest, XLV

FundExpense ratioFee$10k

XLV0.08%$8

SBIO0.50%$50

End-of-day Nov 13, 2026 · fee on $10,000 a year

Yields: SBIO, XLV

1Y

1.35%highest, XLV

FundTrailing yieldYield

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+34.9%

VIGVanguard

+16.0%

+34.9%Year to date+16.0%

2.9%Yield1.4%

$124BAssets$109B

2–0SCHD wins

End-of-day Nov 13, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+6.7%

JEPIJ.P. Morgan

+8.2%

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

Year to dateJan 1 → Nov 13

+23.5%

+20.4%1 yearTotal return+25.6%

+32.1%3 years · per year$10,000 became $23,054 · $15,490+15.7%

+3.6%5 years · per year$10,000 became $11,920 · $15,419+9.0%

0.50%Expense ratio$50 · $8 a year on $10k · lower is better0.08%

0.00%Trailing 12-mo yield$0 · $135 a year on $10k1.35%

−29.2%Worst dropSmaller is better−10.5%

33.5%VolatilityLower is calmer16.8%

SBIOXLV Winner of the row, in its colourEach row: the bigger of the two fills its side

1–7XLV wins

End-of-day Nov 13, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

4.5%ORKAnot top 5

4.1%CGONnot top 5

3.7%MANEnot top 5

3.4%DNTHnot top 5

3.3%EWTXnot top 5

Held in common0.0%

End-of-day Nov 13, 2026 · share of each fund

SBIO vs XLV Returns, Every Period

5Y

ALPSSBIO

+3.6%

5 years, per year

XLVSPDR

+9.0%

5 years, per year

SBIOXLVFaded: behind in that period

1–3XLV wins

End-of-day Nov 13, 2026 · dividends in · faded = behind in that period

SBIO vs XLV

YTD

ALPSSBIO

+8.6%

XLVSPDR

+23.5%

+8.6%Year to date+23.5%

−29.2%Worst drop · 1Y−10.5%

33.5%Volatility · 1Y16.8%

0.0%Yield1.4%

$186MAssets$50.6B

4–0XLV wins

End-of-day Nov 13, 2026 · smaller drop and lower volatility win

$10k

XLV1.35%$135

SBIO0.00%$0

End-of-day Nov 13, 2026 · trailing 12-month yield

Income After Fees on $10,000

1Y

$127most kept, XLV

XLV$135 − $8 = $127

SBIO$0 − $50 = −$50

KeptFee

End-of-day Nov 13, 2026 · yield in dollars minus the fee

Overlap: SBIO, XLV

Today

0.0%most shared, SBIO and XLV

SBIOXLV

SBIO—0.0%

XLV0.0%—

End-of-day Nov 13, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

1Y

+25.6%XLV, at 16.8% volatility

XLVWorst drop−10.5%16.8% vol

SBIOWorst drop−29.2%33.5% vol

End-of-day Nov 13, 2026 · up and left is better

Paid More vs Made More

YTD

XLVSBIO

+23.5%Year to date+8.6%

1.4%Yield0.0%

+25.6%Past year+20.4%

0.08%Fee0.50%

4–0XLV wins

End-of-day Nov 13, 2026

+6.7%Year to date+8.2%

12.4%Yield7.9%

$42.5BAssets$47.1B

1–1level

End-of-day Nov 13, 2026

Year to date

+11.5%

1.0%Yield1.0%

$186BAssets$807B

0–0level

End-of-day Nov 13, 2026

Loading…

SBIO and XLV

Head to Head

More Ways to See the Pairs

Cost, Income and Risk

Popular Pairs Near These Two